tradingkey.logo

Bio-Techne drops as quarterly sales miss estimates

ReutersNov 5, 2025 12:56 PM

Shares of bio-tech firm Bio-Techne TECH.O fall about 9% at $55.44 in premarket trading

Reports Q1 sales drop 1% to $286.6 million, missing analysts' estimates of $291.2 million - data compiled by LSEG

Posts Q1 adjusted EPS in line with estimate of 42 cents

"We observed encouraging signs of stabilization in our US academic end market," says CEO Kim Kelderman, adding "funding headwinds persisted for emerging biotech companies"

As of last close stock down 15.2% YTD

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI